A carregar...

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors

Immune checkpoint inhibitors (ICIs) have demonstrated significant clinical impact in improving overall survival of several malignancies associated with poor outcomes; however, only 20–40% of patients will show long-lasting survival. Further clarification of factors related to treatment response can...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Pharmacokinet
Main Authors: Centanni, Maddalena, Moes, Dirk Jan A. R., Trocóniz, Iñaki F., Ciccolini, Joseph, van Hasselt, J. G. Coen
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6584248/
https://ncbi.nlm.nih.gov/pubmed/30815848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-019-00748-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!